111 related articles for article (PubMed ID: 10404216)
1. Solution structure of core binding factor beta and map of the CBF alpha binding site.
Huang X; Peng JW; Speck NA; Bushweller JH
Nat Struct Biol; 1999 Jul; 6(7):624-7. PubMed ID: 10404216
[TBL] [Abstract][Full Text] [Related]
2. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
3. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.
Goger M; Gupta V; Kim WY; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):620-3. PubMed ID: 10404215
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
[TBL] [Abstract][Full Text] [Related]
6. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
7. Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.
Namba K; Abe M; Saito S; Satake M; Ohmoto T; Watanabe T; Sato Y
Oncogene; 2000 Jan; 19(1):106-14. PubMed ID: 10644985
[TBL] [Abstract][Full Text] [Related]
8. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
9. Overexpression, purification, and biophysical characterization of the heterodimerization domain of the core-binding factor beta subunit.
Huang X; Crute BE; Sun C; Tang YY; Kelley JJ; Lewis AF; Hartman KL; Laue TM; Speck NA; Bushweller JH
J Biol Chem; 1998 Jan; 273(4):2480-7. PubMed ID: 9442100
[TBL] [Abstract][Full Text] [Related]
10. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
11. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
[TBL] [Abstract][Full Text] [Related]
13. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
Narayana N; Hua Q; Weiss MA
J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
[TBL] [Abstract][Full Text] [Related]
14. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
15. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of a mutant of transcription factor 1: implications for enhanced DNA binding.
Liu W; Vu HM; Geiduschek EP; Kearns DR
J Mol Biol; 2000 Sep; 302(4):821-30. PubMed ID: 10993726
[TBL] [Abstract][Full Text] [Related]
17. Structural approach to a novel tandem repeat DNA-binding domain, STPR, by CD and NMR.
Saito S; Aizawa T; Kawaguchi K; Yamaki T; Matsumoto D; Kamiya M; Kumaki Y; Mizuguchi M; Takiya S; Demura M; Kawano K
Biochemistry; 2007 Feb; 46(7):1703-13. PubMed ID: 17249695
[TBL] [Abstract][Full Text] [Related]
18. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
[TBL] [Abstract][Full Text] [Related]
19. Requisite roles of Runx2 and Cbfb in skeletal development.
Komori T
J Bone Miner Metab; 2003; 21(4):193-7. PubMed ID: 12811622
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]